Arachidonic acid causes postischemic dysfunction in control but not diabetic hearts

Area of Science:

• Cardiovascular Physiology
• Metabolic Disease Research

Background:

• Diabetes mellitus is a significant risk factor for cardiovascular complications, including those related to myocardial ischemia and reperfusion.
• The role of arachidonic acid metabolites, such as prostacyclin, in cardiac function during ischemia-reperfusion injury is not fully understood, especially in the context of diabetes.

Purpose of the Study:

• To investigate the effects of arachidonic acid on cardiac function and prostacyclin release in control versus diabetic rat hearts subjected to ischemia-reperfusion.
• To determine if diabetes alters the heart's response to arachidonic acid and its potential role in free radical production.

Main Methods:

• Isovolumic perfusion of control and diabetic rat hearts.
• Induction of global ischemia followed by reperfusion.
• Administration of arachidonic acid and assessment of contractile function recovery.
• Measurement of prostacyclin release.
• Evaluation of the effects of oxygen free radical scavengers and indomethacin.

Main Results:

• Diabetic hearts exhibited similar recovery of contractile function post-ischemia compared to control hearts.
• Arachidonic acid caused significant post-ischemic dysfunction in control hearts but not in diabetic hearts.
• Arachidonic acid augmented prostacyclin release in control hearts but not in diabetic hearts.
• Arachidonic acid-induced dysfunction in control hearts was attenuated by superoxide dismutase plus catalase, suggesting a role for free radicals.

Conclusions:

• Chronic diabetes confers tolerance to arachidonic acid-induced post-ischemic dysfunction.
• The blunted prostacyclin response to arachidonic acid in diabetic hearts may impair their ability to counteract thromboxane-mediated effects during ischemia-reperfusion.
• This defect could increase the risk of ischemic reperfusion complications in diabetic individuals.